lifestyle.projectdiaspora.org

Author: Vicore Pharma Holding

Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)

May 7, 2026
Interim Report January – March 2026

May 6, 2026
Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference

May 5, 2026
Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis

May 5, 2026
Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)

May 2, 2026
Vicore Publishes the Annual Report for 2025

May 1, 2026
Vicore Pharma to Present at Upcoming Investor Conferences

April 29, 2026
Vicore Pharma Elevates Leadership Team Ahead of Key Clinical and Corporate Milestones

April 28, 2026
Year-End Report 2025

February 27, 2026
Vicore Pharma to Present at Upcoming Investor Conferences

February 26, 2026